Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-02

Clinical Trial Update: Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy

View source ↗

Summary

A clinical trial is investigating salivary microRNA as a biomarker in endometriosis and its correlation with response to progestin therapy. The study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Udine | Conditions: Endometriosis | Status: RECRUITING